Cantor Fitzgerald Investment Advisors L.P. acquired a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 4,510 shares of the company's stock, valued at approximately $1,457,000. Several other institutional investors
Delta Investment Management LLC purchased a new stake in Elevance Health, Inc. (NYSE: ELV) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 23,612 shares of the company's stock, valued at approximately $7,629,000. Elevance Health makes up 1.4%
Cwm LLC lifted its holdings in Elevance Health, Inc. (NYSE: ELV) by 167.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,088 shares of the company's stock after acquiring an additional 11,962 shares during the period. Cwm LLC's
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
Diversified Trust Co trimmed its holdings in Elevance Health, Inc. (NYSE: ELV) by 5.7% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 34,151 shares of the company's stock after selling 2,058 shares during the period. Diversified Trust Co's holdings in Elevance Health were worth $11,035,000
Deprince Race and Zollo Inc. acquired a new stake in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 64,020 shares of the company's stock, valued at approximately $20,686,000. A number of
Live Updates Market Gainers 1 hour ago Live Freeport-McMoRan (NYSE: FCX) stock is gaining 2.8% today. Target (NYSE: TGT) is tacking on approximately 2%. Workday (Nasdaq: WDAY) is up 1.5%. Elevance Health (NYSE: ELV) is gaining 1.2% on the day. Bullish on 2026 3 hours ago Live In one of the more bullish outlooks on... Live Nasdaq Composite: Markets Eye Finish Line as Nvidia Finds Its Groove.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (Inte.
Dynamic Advisor Solutions LLC lessened its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 24.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,055 shares of the company's stock after selling 1,979 shares during the
Canandaigua National Bank and Trust Co. bought a new stake in Elevance Health, Inc. (NYSE: ELV) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 1,834 shares of the company's stock, valued at approximately $593,000. A number of other large
